SE7411806L - - Google Patents

Info

Publication number
SE7411806L
SE7411806L SE7411806A SE7411806A SE7411806L SE 7411806 L SE7411806 L SE 7411806L SE 7411806 A SE7411806 A SE 7411806A SE 7411806 A SE7411806 A SE 7411806A SE 7411806 L SE7411806 L SE 7411806L
Authority
SE
Sweden
Application number
SE7411806A
Other versions
SE410600B (sv
Inventor
C Fauran
G Bourgery
G Raynaud
C Gouret
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7333831A external-priority patent/FR2244459A1/fr
Priority claimed from FR7410327A external-priority patent/FR2265386A2/fr
Application filed by Delalande Sa filed Critical Delalande Sa
Publication of SE7411806L publication Critical patent/SE7411806L/xx
Publication of SE410600B publication Critical patent/SE410600B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7411806A 1973-09-20 1974-09-19 Sett att framstella nya arylaminopyrimidinderivat SE410600B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7333831A FR2244459A1 (en) 1973-09-20 1973-09-20 2-Arylamino-pyrimidines - useful as sedatives, antiinflammatory, anti-ulcer, vasodilating, anticholinergic and anti-broncho- constricting agents and diuretics
FR7410327A FR2265386A2 (en) 1974-03-26 1974-03-26 2-Arylamino-pyrimidines - useful as sedatives, antiinflammatory, anti-ulcer, vasodilating, anticholinergic and anti-broncho- constricting agents and diuretics

Publications (2)

Publication Number Publication Date
SE7411806L true SE7411806L (fr) 1975-03-21
SE410600B SE410600B (sv) 1979-10-22

Family

ID=26217948

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7411806A SE410600B (sv) 1973-09-20 1974-09-19 Sett att framstella nya arylaminopyrimidinderivat

Country Status (12)

Country Link
US (1) US3978055A (fr)
JP (1) JPS5088079A (fr)
CA (1) CA1008074A (fr)
CH (1) CH593266A5 (fr)
DE (1) DE2444426A1 (fr)
ES (1) ES429869A1 (fr)
GB (1) GB1430729A (fr)
IT (1) IT1062796B (fr)
LU (1) LU70791A1 (fr)
NL (1) NL7412494A (fr)
SE (1) SE410600B (fr)
SU (1) SU645569A3 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1534593A (en) * 1976-09-03 1978-12-06 Soc D Etudes Prod Chimique N-2,6-dichlorophenyl-2-aminopyrimidine and therapeutic compositions containing it
JPS57203072A (en) * 1981-06-05 1982-12-13 Sankyo Co Ltd 4-anilinopyrimidine derivative, its preparation, antidepressant comprising it as active ingredient
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
US5254555A (en) * 1989-10-30 1993-10-19 Beecham Group P.L.C. Amino pyrimidin-7-yl substituted benzopyrans for treatment of hypertension
US7481790B2 (en) * 2000-12-27 2009-01-27 Advanced Cardiovascular Systems, Inc. Vessel enlargement by arteriogenic factor delivery
DE10133665A1 (de) * 2001-07-11 2003-01-30 Boehringer Ingelheim Pharma Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
US20030055263A1 (en) * 2001-07-11 2003-03-20 Boehringer Ingelheim Pharma Kg Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production
US7320989B2 (en) * 2003-02-28 2008-01-22 Encysive Pharmaceuticals, Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
CA2517166A1 (fr) * 2003-02-28 2004-09-16 Encysive Pharmaceuticals Inc. Pyridine, pyrimidine, quinoline, quinazoline et naphtalene, antagonistes du recepteur de l'urotensine ii
US8455489B2 (en) 2003-11-10 2013-06-04 Exelixis, Inc. Substituted pyrimidine compositions and methods of use
EP1689715B1 (fr) 2003-12-03 2011-02-09 YM BioSciences Australia Pty Ltd Inhibiteurs de la tubuline
PE20151413A1 (es) 2012-11-21 2015-10-23 Ptc Therapeutics Inc Inhibidores de bmi-1 de pirimidina inversa sustituida
AR093580A1 (es) 2013-08-30 2015-06-10 Ptc Therapeutics Inc Inhibidores bmi-1 de pirimidina sustituidos
EP3071553A4 (fr) 2013-11-21 2017-08-02 PTC Therapeutics, Inc. Inhibiteurs de bmi-1 à base de pyridine et de pyrazine substituées
CN104262263B (zh) * 2014-08-29 2017-01-11 西安交通大学 一种N,6二苯基嘧啶-4-胺类Bcr-Abl抑制剂及其制备方法和应用
WO2020055544A2 (fr) 2018-08-17 2020-03-19 Ptc Therapeutics, Inc. Méthode de traitement du cancer du pancréas
MX2021010398A (es) * 2019-02-28 2022-01-18 Ptc Therapeutics Inc Metodo para tratar un mieloma multiple.
US20220152024A1 (en) * 2019-03-27 2022-05-19 Ptc Therapeutics, Inc. Combinations useful in a method for treating sarcoma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321478A (en) * 1963-09-20 1967-05-23 American Cyanamid Co Aminoethoxyphenyl amine, ether, and sulfide derivatives of pyrimidine

Also Published As

Publication number Publication date
ES429869A1 (es) 1976-10-01
NL7412494A (nl) 1975-03-24
CH593266A5 (fr) 1977-11-30
US3978055A (en) 1976-08-31
SU645569A3 (ru) 1979-01-30
LU70791A1 (fr) 1975-06-11
GB1430729A (en) 1976-04-07
SE410600B (sv) 1979-10-22
AU7344174A (en) 1976-03-25
DE2444426A1 (de) 1975-03-27
CA1008074A (fr) 1977-04-05
JPS5088079A (fr) 1975-07-15
IT1062796B (it) 1985-01-31

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU476761B2 (fr)
AU465372B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU465453B2 (fr)
AU465434B2 (fr)
AU471343B2 (fr)
AU450229B2 (fr)
AU476714B2 (fr)
AR201229Q (fr)
AU466283B2 (fr)
AU476696B2 (fr)
AU472848B2 (fr)
AR199451A1 (fr)
AU477823B2 (fr)
AU461342B2 (fr)
AU471461B2 (fr)
AR200256A1 (fr)
AU476873B1 (fr)
AR210729A1 (fr)
AR201432A1 (fr)